Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Efficacy of phase 1 trials in malignant pleural mesothelioma: description of a series of patients at a single institutionJ Raphael, G Le Teuff, A Hollebecque, et al.
British Journal of Anaesthesia|June 28, 2012
Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indicesX Monnet, M Dres, A Ferré, et al.
Epidemiology and Infection|January 13, 2009
Markov modelling of HIV infection evolution in the HAART eraC Binquet, G Le Teuff, M Abrahamovicz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2018
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 studyB Fresneau, D Orbach, C Faure-Conter, et al.
British Journal of Cancer|October 6, 2011
Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastomaC-H Gattolliat, L Thomas, S A Ciafrè, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2017
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancerM-S Tsao, G Le Teuff, F A Shepherd, et al.
Clinical Genetics|March 17, 2017
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriersM Muller, S Ferlicot, M Guillaud-Bataille, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2026
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II studyG M Camilleri, M A Loriot, G Le Teuff, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastasesY Loriot, L Pagliaro, A Fléchon, et al.
Pageof 2